OBJECTIVE: Lack of insight affects the management of schizophrenia. The interrelationship between lack of insight and illness attributes in patients with schizophrenia who commit violent acts is important and underresearched. METHOD: One hundred fifteen violent patients with schizophrenia in a jail or court psychiatric clinic were evaluated on measures of symptoms, illness severity, insight into illness, and the legal consequences of their illness ("forensic insight"). A sample of nonviolent patients served as a comparison group. RESULTS: Compared with the nonviolent cohort, violent patients were more symptomatic, had poorer functioning, and had a more prominent lack of insight. Deficits of insight into illness coexisted with a lack of forensic insight, which was also associated with psychosis. CONCLUSIONS: Patients with schizophrenia who commit violent acts have insight deficits, including lack of awareness of the legal implications of their behavior. Targeted interventions to improve insight and treatment compliance in this population are warranted.
OBJECTIVE: Lack of insight affects the management of schizophrenia. The interrelationship between lack of insight and illness attributes in patients with schizophrenia who commit violent acts is important and underresearched. METHOD: One hundred fifteen violent patients with schizophrenia in a jail or court psychiatric clinic were evaluated on measures of symptoms, illness severity, insight into illness, and the legal consequences of their illness ("forensic insight"). A sample of nonviolent patients served as a comparison group. RESULTS: Compared with the nonviolent cohort, violent patients were more symptomatic, had poorer functioning, and had a more prominent lack of insight. Deficits of insight into illness coexisted with a lack of forensic insight, which was also associated with psychosis. CONCLUSIONS:Patients with schizophrenia who commit violent acts have insight deficits, including lack of awareness of the legal implications of their behavior. Targeted interventions to improve insight and treatment compliance in this population are warranted.
Authors: Valerie Moulin; Julie Palix; Luis Alameda; M Mehdi Gholamrezaee; Philipp S Baumann; Jacques Gasser; Julien Elowe; Alessandra Solida; Philippe Conus Journal: Can J Psychiatry Date: 2017-06-28 Impact factor: 4.356
Authors: Greg Greenberg; Robert A Rosenheck; Steven K Erickson; Rani A Desai; Elina A Stefanovics; Marvin Swartz; Richard S E Keefe; Joe McEvoy; T Scott Stroup Journal: Community Ment Health J Date: 2010-11-28
Authors: Gary Brucato; Paul S Appelbaum; Jeffrey A Lieberman; Melanie M Wall; Tianshu Feng; Michael D Masucci; Rebecca Altschuler; Ragy R Girgis Journal: Neuropsychopharmacology Date: 2017-07-26 Impact factor: 7.853
Authors: Gary Brucato; Paul S Appelbaum; Michael D Masucci; Stephanie Rolin; Melanie M Wall; Mark Levin; Rebecca Altschuler; Michael B First; Jeffrey A Lieberman; Ragy R Girgis Journal: Neuropsychopharmacology Date: 2018-12-27 Impact factor: 7.853
Authors: Rudolf Slamanig; Andreas Reisegger; Hildegard Winkler; Giovanni de Girolamo; Giuseppe Carrà; Cristina Crocamo; Heiner Fangerau; Inga Markiewicz; Janusz Heitzman; Hans Joachim Salize; Marco Picchioni; Johannes Wancata Journal: Front Psychiatry Date: 2021-05-10 Impact factor: 4.157